First Time Loading...
G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 836.25 INR 0.63% Market Closed
Updated: Jun 1, 2024

Glenmark Life Sciences Ltd
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Life Sciences Ltd
Total Liabilities Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Total Liabilities
₹5.6B
CAGR 3-Years
-23%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Liabilities
₹106.1B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Liabilities
₹60.1B
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
6%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Liabilities
₹196.2B
CAGR 3-Years
-5%
CAGR 5-Years
-8%
CAGR 10-Years
8%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Total Liabilities
₹94.5B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Liabilities
₹80.4B
CAGR 3-Years
-3%
CAGR 5-Years
-5%
CAGR 10-Years
10%

See Also

What is Glenmark Life Sciences Ltd's Total Liabilities?
Total Liabilities
5.6B INR

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Total Liabilities amounts to 5.6B INR.

What is Glenmark Life Sciences Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-16%

Over the last year, the Total Liabilities growth was 0%. The average annual Total Liabilities growth rates for Glenmark Life Sciences Ltd have been -23% over the past three years , -16% over the past five years .